Navigation Links
Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions
Date:2/3/2010

PITTSBURGH, Feb. 3 /PRNewswire/ -- An era of personalized medicine is redefining how patients and doctors work together to fight cancer.  Now, drug response markers such as the ChemoFx® diagnostic test show promising results which can help to determine individual cancer treatment plans when using various chemotherapeutic agents.

ChemoFx® is a test produced by Precision Therapeutics, Inc., a life sciences company in Pittsburgh, Pennsylvania. With the introduction of this innovative drug response marker, the company has pioneered a method of identifying cancer cell response and sensitivity to various chemotherapeutic and biologic agents at the biopsy stage -- long before a patient actually begins chemotherapy -- providing a custom blueprint of a patient's probable tumor response.

The result is valuable insight into which chemotherapy drugs are most likely to work in an individual cancer patient's own body -- along with those that are unlikely to be effective in shrinking and killing the cancerous tumor.  This information can then be used to help guide chemotherapy treatment decisions, according to company officials.

"Patients and their physicians will have an understanding of how chemo will impact the cancer cells themselves long before it impacts the patient," says Sean McDonald, CEO of Precision Therapeutics.  "By testing multiple agents on a patient's cancer cells in the lab, ChemoFx® determines the chemotherapies that are more likely to be effective and avoid those that are likely to be ineffective, giving patients a powerful advantage in their fight against cancer."

The diagnostic test works by taking a sample of a patient's tumor, which is removed during biopsy or surgery, and sending that sample to the Precision Therapeutics labo
'/>"/>

SOURCE Precision Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
2. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
3. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
4. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
5. Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics
6. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
7. Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation
8. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
9. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
10. For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold
11. Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Jazz Pharmaceuticals plc ... will report its 2014 second quarter financial results on ... financial markets.  Company management will host a live audio ... p.m. IST to provide a business and financial update ... Interested parties may access the live audio webcast via ...
(Date:7/22/2014)... 2014  Decision Resources Group finds that the market for ... will remain relatively stagnant at a value of around $80 ... coronary intervention (PCI) volumes are growing faster in ... the United States and ... the increase in penetration of PCI procedures relative to coronary ...
(Date:7/22/2014)... ALBANY, New York , July 22, 2014 ... published by Transparency Market Research "Process Spectroscopy Market (Technology Types ... infrared (FT-IR) spectroscopy) Market - Global Industry Analysis, Size, Share, ... valued at USD 714.5 million in 2012 and is expected ... 2019. North America was ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4
... , , New collaborative research program to study effects ... Dec. 30 A new research program called the Medication ... to study the effects of prescription medications used during pregnancy. ... Drug Administration and researchers at the HMO Research Network Center ...
... , BOSTON, Dec. 30 Solos Endoscopy, Inc. (Pink ... to a prosperous 2010, following a solid year in 2009, due ... the closing months of 2009, Solos Endoscopy, Inc. has taken the ... of surgical endoscopy instruments. This will allow the MammoView(TM) line to ...
Cached Medicine Technology:FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 2FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 3Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:7/22/2014)... American Society of Hematology (ASH) will honor Michael DeBaun, ... Robert P. Hebbel, MD, of the University of Minnesota ... Prize for their significant research advances in the area ... named for the late Ernest Beutler, MD, a past ... years, is a two-part lectureship that recognizes major translational ...
(Date:7/22/2014)... Marc, Ph.D., director of research at the University of ... by the International Society of Eye Research (ISER) as ... 2014 Paul Kayser International Award in Retina Research., The ... has made a significant contribution to the understanding of ... this week at the ISER Biennial Meeting in San ...
(Date:7/22/2014)... D.C. (PRWEB) July 22, 2014 ... “Ensuring Seniors Access to Local Pharmacies Act of ... Medicare Part D would undermine the availability of ... spending by $21 billion over the next 10 ... Company released by the Pharmaceutical Care Management Association ...
(Date:7/22/2014)... may share certain pathogenic mechanisms with cancer, according to ... Linda Kusner, Ph.D. , published in PLOS ... work shows that the very same inhibitors of apoptosis, ... cells that produce autoimmune diseases. Henry Kaminski, M.D. ... GW School of Medicine and Health Sciences (SMHS), as ...
(Date:7/22/2014)... July 22, 2014 The Beryl Institute ... third annual Institute Scholar Program. These offerings reinforce the ... patient experience in healthcare and the need for rigorous ... grant and scholar programs are intended to ... Value of focusing on the patient experience before, ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3
... they took the advice of the government in refusing to ... three children. Swindon NHS chiefs said that the denial of ... advice from their superiors.// ,Herceptin is not licensed ... are suing the NHS for its failure to provide the ...
... the National Heart, Lung, and Blood Institute (NHLBI), has ... high blood pressure., ,The education would be given ... who have been trained to educate other physicians in ... help doctors and patients prevent and better treat high ...
... disease), Russia has put a stop and a aban on ... animal feed from the Argentine province of Corrientes. The action ... by the the Agriculture Ministry of Russia. ,The ... health body), about an outbreak of the disease in cattle ...
... vaccine in the US is expected to enhance the supply ... preparation. Currently, the Australian manufacturer, //CSL, is selling the flu ... to a Swiss based Berna Biotech enables distribution of the ... have expressed hope over initiation of clinical trials in the ...
... immediately after birth may be the best indicator of subsequent ... fatigues two weeks after the birth of their child were ... mothers are tired right after having a baby - it ... and heal from the physical and mental stressors of childbirth," ...
... University Medical Center have found that the lethal impact ... anticipated. Researchers from the Mailman School of Public Health ... study, which// appears in the February issue of Diabetes ... and treat periodontal disease should be considered a standard ...
Cached Medicine News:Health News:Extension Education for Blood Pressure advice! 2Health News:Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression 2Health News:Gum Disease Affects Diabetic Children Earlier Than Anticipated 2
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... the most advanced image-guided platforms available ... of an expandable platform. In addition ... supports new applications in electromagnetics (EM). ... well as the ability to track ...
... The Mayfield 2000 series radiolucent headrest system ... intraoperative digital subtraction angiography. This system is ... skull clamp and the Mayfield radiolucent base ... designed for patient positioning in the prone ...
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Medicine Products: